Form 4 for YARW Yarrow Bioscience, Inc.

Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-01 · accession 0001209191-24-000467 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-01-03	2024-01-01	YARW	Harsch Mutya	CLO, GC	A - Grant	$0.00	+62.5K	149.6K	+72%	$0
D	2024-01-03	2024-01-02	YARW	Harsch Mutya	CLO, GC	F - Tax	$2.28	-161	149.4K	-0.1%	-$367.08
D	2024-01-03	2024-01-01	YARW	Harsch Mutya	CLO, GC	A - Grant	$0.00	+62.5K	62.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-01	A	A	62,500	$0.00	149,596	D	—	—	(F2) The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date. (F1) Grant to the Reporting Person of a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
2	Common	Common Stock	2024-01-02	F	D	161	$2.28	149,435	D	—	—	(F3) Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
3	Derivative	Stock Option (right to buy)	2024-01-01	A	A	62,500	$0.00	62,500	D	$2.33 · — to 2033-12-31	62,500 Common Stock	(F4) The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date.